Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury.
Pais GM, Avedissian SN, O'Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Lamar PC, Cluff C, Gulati A, Fitzgerald JC, Downes KJ, Zuppa AF, Scheetz MH. Pais GM, et al. Among authors: cluff c. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00079-19. doi: 10.1128/AAC.00079-19. Print 2019 Jul. Antimicrob Agents Chemother. 2019. PMID: 30988153 Free PMC article.
Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.
Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH. Rhodes NJ, et al. Among authors: cluff c. Antimicrob Agents Chemother. 2016 Sep 23;60(10):5742-51. doi: 10.1128/AAC.00591-16. Print 2016 Oct. Antimicrob Agents Chemother. 2016. PMID: 27431226 Free PMC article.
Correction for Rhodes et al., Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.
Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH. Rhodes NJ, et al. Among authors: cluff c. Antimicrob Agents Chemother. 2017 Mar 24;61(4):e00185-17. doi: 10.1128/AAC.00185-17. Print 2017 Apr. Antimicrob Agents Chemother. 2017. PMID: 28341810 Free PMC article. No abstract available.
Dose, duration, and animal sex predict vancomycin-associated acute kidney injury in preclinical studies.
O'Donnell JN, Rhodes NJ, Miglis CM, Catovic L, Liu J, Cluff C, Pais G, Avedissian S, Joshi MD, Griffin B, Prozialeck W, Gulati A, Lodise TP, Scheetz MH. O'Donnell JN, et al. Among authors: cluff c. Int J Antimicrob Agents. 2018 Feb;51(2):239-243. doi: 10.1016/j.ijantimicag.2017.08.012. Epub 2017 Aug 10. Int J Antimicrob Agents. 2018. PMID: 28803934 Free PMC article. Review.
24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.
O'Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Miglis CM, Joshi MD, Venkatesan N, Pais G, Cluff C, Lamar PC, Briyal S, Day JZ, Gulati A, Scheetz MH. O'Donnell JN, et al. Among authors: cluff c. Antimicrob Agents Chemother. 2017 Oct 24;61(11):e00416-17. doi: 10.1128/AAC.00416-17. Print 2017 Nov. Antimicrob Agents Chemother. 2017. PMID: 28807910 Free PMC article.
Factors that influence women's enrolment and ongoing participation in a partially decentralised randomised controlled dermatology trial: a qualitative interview study with participants in the SAFA (Spironolactone for Adult Female Acne) trial.
Boxall C, Renz S, Eminton Z, Nuttall J, Saji A, Cluff C, Wilcox C, Muller I, Layton AM, Soulsby I, Santer M. Boxall C, et al. Among authors: cluff c. Trials. 2023 Oct 12;24(1):661. doi: 10.1186/s13063-023-07630-4. Trials. 2023. PMID: 37821899 Free PMC article. Clinical Trial.
Low-Value Prostate Cancer Screening Among Young Men With Private Insurance.
Lange SM, Vehawn J, Choudry MM, Ambrose JP, Cluff CM, Haaland BA, Paudel N, Chipman J, Hanson HA, O'Neil BB. Lange SM, et al. Among authors: cluff cm. Urol Pract. 2024 Jan;11(1):110-115. doi: 10.1097/UPJ.0000000000000461. Epub 2023 Sep 25. Urol Pract. 2024. PMID: 37747942
Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology.
Michaud JP, Hallé M, Lampron A, Thériault P, Préfontaine P, Filali M, Tribout-Jover P, Lanteigne AM, Jodoin R, Cluff C, Brichard V, Palmantier R, Pilorget A, Larocque D, Rivest S. Michaud JP, et al. Among authors: cluff c. Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1941-6. doi: 10.1073/pnas.1215165110. Epub 2013 Jan 15. Proc Natl Acad Sci U S A. 2013. PMID: 23322736 Free PMC article.
Discovery of N-(3-fluorophenyl)-1-[(4-([(3S)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the first small molecule motilin receptor agonist clinical candidate.
Westaway SM, Brown SL, Fell SC, Johnson CN, MacPherson DT, Mitchell DJ, Myatt JW, Stanway SJ, Seal JT, Stemp G, Thompson M, Lawless K, McKay F, Muir AI, Barford JM, Cluff C, Mahmood SR, Matthews KL, Mohamed S, Smith B, Stevens AJ, Bolton VJ, Jarvie EM, Sanger GJ. Westaway SM, et al. Among authors: cluff c. J Med Chem. 2009 Feb 26;52(4):1180-9. doi: 10.1021/jm801332q. J Med Chem. 2009. PMID: 19191554
31 results